Stock INO INOVIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Inovio Pharmaceuticals, Inc.

Equities

INO

US45773H4092

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
10.57 USD +4.40% Intraday chart for Inovio Pharmaceuticals, Inc. +9.19% +72.71%
Apr. 16 Powell Comments, Middle East Tensions in Focus as US Equity Futures Gain Pre-Bell MT
Apr. 16 Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
PR
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
PR
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
AQ
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
PR
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PR
INOVIO Reports Inducement Grant Under Inducement Plan
PR
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
PR
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
PR
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
PR
Inovio: Q3 Earnings Snapshot
AQ
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
PR
INOVIO Reports Inducement Grants Under Inducement Plan
PR
INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023
PR
News-Driven Nano-Cap Stocks Momentum Watchlist (IMRFF, SUUFF, IFUS, INO)
AQ
INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA under Accelerated Approval Program
AQ
Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million
PR
INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference
PR
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
AQ
Inovio: Q2 Earnings Snapshot
AQ
INOVIO Reports Inducement Grants Under Inducement Plan
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INO Stock
  4. News Inovio Pharmaceuticals, Inc.
  5. Press Releases